Cargando…
Protein Kinases: Potential Drug Targets Against Schistosoma japonicum
Schistosoma japonicum (S. japonicum) infection can induce serious organ damage and cause schistosomiasis japonica which is mainly prevalent in Asia and currently one of the most seriously neglected tropical diseases. Treatment of schistosomiasis largely depends on the drug praziquantel (PZQ). Howeve...
Autores principales: | Wu, Kaijuan, Zhai, Xingyu, Huang, Shuaiqin, Jiang, Liping, Yu, Zheng, Huang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282181/ https://www.ncbi.nlm.nih.gov/pubmed/34277472 http://dx.doi.org/10.3389/fcimb.2021.691757 |
Ejemplares similares
-
Bacillus amyloliquefaciens alleviates the pathological injuries in mice infected with Schistosoma japonicum by modulating intestinal microbiome
por: Chen, Hao, et al.
Publicado: (2023) -
Proteomics Investigations of Potential Protein Biomarkers in Sera of Rabbits Infected With Schistosoma japonicum
por: Bi, Nian-Nian, et al.
Publicado: (2021) -
The Potential Role of MicroRNA‐124‐3p in Growth, Development, and Reproduction of Schistosoma japonicum
por: Zhou, Xue, et al.
Publicado: (2022) -
Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
por: Liu, Zhilong, et al.
Publicado: (2022) -
Schistosoma japonicum Cystatin Alleviates Sepsis Through Activating Regulatory Macrophages
por: Xie, Hong, et al.
Publicado: (2021)